Terns Pharmaceuticals (TERN) Insider Trading & Ownership $4.53 +0.53 (+13.25%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$4.60 +0.06 (+1.43%) As of 07/8/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Terns Pharmaceuticals (NASDAQ:TERN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.50%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$5.31MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.06M Get TERN Insider Trade Alerts Want to know when executives and insiders are buying or selling Terns Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TERN Insider Buying and Selling by Quarter Terns Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/1/2025Emil KuriakoseInsiderSell853$4.27$3,642.31 6/27/2025Andrew GengosCFOBuy10,000$3.93$39,300.00 6/25/2025Amy L BurroughsCEOBuy23,314$3.87$90,225.18 6/16/2025Andrew GengosCFOBuy5,000$3.95$19,750.00 6/13/2025Andrew GengosCFOBuy10,000$3.73$37,300.00 4/1/2025Emil KuriakoseInsiderSell952$2.49$2,370.48 1/6/2025Jill M. QuigleyDirectorSell8,760$5.79$50,720.40 1/6/2025Mark J VignolaCFOSell9,059$5.80$52,542.20 1/2/2025Emil KuriakoseInsiderSell4,481$5.71$25,586.51 1/2/2025Jill M QuigleyDirectorSell6,240$5.72$35,692.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/2/2025Mark J VignolaCFOSell8,129$5.72$46,497.88 12/5/2024Amy L BurroughsCEOBuy15,450$7.15$110,467.50 11/30/2024Amy L BurroughsCEOBuy510$5.11$2,606.10 11/30/2024Melita Sun JungInsiderBuy2,250$5.11$11,497.50 9/12/2024Hongbo LuDirectorBuy476,190$10.50$4,999,995.00 9/10/2024Mark J VignolaCFOSell10,000$11.00$110,000.00 9/9/2024Jill M QuigleyDirectorSell17,235$10.00$172,350.00 8/1/2024Jill M QuigleyDirectorSell6,143$7.68$47,178.24 7/15/2024Carl L GordonDirectorSell50,976$10.00$509,760.00 (Data available from 1/1/2013 forward) TERN Insider Trading Activity - Frequently Asked Questions Who is on Terns Pharmaceuticals' Insider Roster? The list of insiders at Terns Pharmaceuticals includes Amy L Burroughs, Andrew Gengos, Biosciences Fund V L.P. Lav, Carl L Gordon, Emil Kuriakose, Hongbo Lu, Jill M Quigley, Mark J Vignola, Melita Sun Jung, Orbimed Advisors Llc, and Vivo Opportunity, Llc. Learn more on insiders at TERN. What percentage of Terns Pharmaceuticals stock is owned by insiders? 1.50% of Terns Pharmaceuticals stock is owned by insiders. Learn more on TERN's insider holdings. Which Terns Pharmaceuticals insiders have been buying company stock? The following insiders have purchased TERN shares in the last 24 months: Amy L Burroughs ($203,298.78), Andrew Gengos ($96,350.00), Hongbo Lu ($4,999,995.00), and Melita Sun Jung ($11,497.50). How much insider buying is happening at Terns Pharmaceuticals? Insiders have purchased a total of 542,714 TERN shares in the last 24 months for a total of $5,311,141.28 bought. Which Terns Pharmaceuticals insiders have been selling company stock? The following insiders have sold TERN shares in the last 24 months: Carl L Gordon ($509,760.00), Emil Kuriakose ($31,599.30), Jill M Quigley ($255,221.04), Mark J Vignola ($209,040.08), and Vivo Opportunity, Llc ($2,122,017.03). How much insider selling is happening at Terns Pharmaceuticals? Insiders have sold a total of 442,011 Terns Pharmaceuticals shares in the last 24 months for a total of $3,178,357.85 sold. Terns Pharmaceuticals Key ExecutivesDr. Erin Quirk M.D. (Age 53)President & Head of Research & Development Compensation: $1.06MDr. Mark Joseph Vignola Ph.D. (Age 46)CFO & Treasurer Compensation: $974.16kMr. Seokho Yoon Esq. (Age 46)COO, General Counsel & Secretary Compensation: $921.05kMs. Amy L. Burroughs M.B.A. (Age 53)CEO & Director 1 recent tradesDr. Jeffrey R. Jasper Ph.D.Senior VP & Head of ResearchDr. Emil T. Kuriakose M.D. (Age 44)Chief Medical Officer Ms. Melita Sun Jung (Age 47)Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies TVTX Insider Ownership GPCR Insider Ownership AUPH Insider Ownership AMPH Insider Ownership DYN Insider Ownership ABCL Insider Ownership PAHC Insider Ownership WVE Insider Ownership ELVN Insider Ownership VERV Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Micron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors? This page (NASDAQ:TERN) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
